The Middle East Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Gazette.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 19, 2026

Mar. 19, 2026

Mutuum Finance Strengthens Presence in Crypto News Today as Token Sales Grow

GlobeNewswire

Mar. 19, 2026

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue…

GlobeNewswire

Mar. 19, 2026

SK pharmteco bekräftigt seine Strategie der drei Geschäftsbereiche und stärkt den Geschäftsbereich für Gentherapie weltweit durch eine Finanzierungszusage

GlobeNewswire

Mar. 19, 2026

SK pharmteco réaffirme sa stratégie à trois unités d’activité et renforce son pôle mondial de thérapie génique grâce à un engagement de financement

GlobeNewswire

Mar. 19, 2026

SK pharmteco, 글로벌 유전자 치료 사업에 투자 확대하며 3대 사업 부문 전략 방향 재확인

GlobeNewswire

Mar. 19, 2026

The Endothelial Glycocalyx Explained: How It Helps Regulate Vascular Function

GlobeNewswire

Mar. 19, 2026

OKYO Pharma Announces Chairman and Founder Acquires Shares

GlobeNewswire

Mar. 19, 2026

Mutuum Finance Gains Attention in Crypto News Today as Presale Nears $21M Raised

GlobeNewswire

Mar. 19, 2026

BriefCast Publishes Transcript: Nasus Pharma NS002 Phase 2 Positive Topline Results Webinar Transcript

GlobeNewswire

Mar. 19, 2026

OKYO Pharma Announces Director Acquires Shares

GlobeNewswire

Mar. 19, 2026

Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

GlobeNewswire

Mar. 19, 2026

Gauzy Strengthens Board and Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

Mar. 19, 2026

BOS Expands India Presence with New Sales Partnership Agreement

GlobeNewswire

Mar. 19, 2026

Curia Expands Glasgow Manufacturing Capacity and Enhances Cell Line Development Platform

GlobeNewswire

Mar. 19, 2026

Lodestar Confirms Significant Rare Earth Mineralization on the Virgin Mountain Property under Option from Globex

GlobeNewswire

Mar. 19, 2026

Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025

GlobeNewswire

Mar. 19, 2026

Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder

GlobeNewswire

Mar. 19, 2026

Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026

GlobeNewswire

Mar. 19, 2026

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

GlobeNewswire

Mar. 19, 2026

MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease

GlobeNewswire